Bristol Myers Squibb (BMY)

Investing Cash Flow

-$4.91B

TTM · Period ending: · USD

BMY logo

BMY Investing Cash Flow

Latest reported-$4.91B
BMY Cash from Investing (-$1.63B → -$4.91B)
High-resolution chart · PNG

BMY investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
-4,132,000,000
-21,352,000,000
-2,295,000,000
-1,062,000,000
-538,000,000
-10,859,000,000
-9,913,000,000
-2,000,000,000
-66,000,000
1,480,000,000
-1,572,000,000
1,216,000,000
-572,000,000
-6,727,000,000
-1,437,000,000
-3,812,000,000
-4,380,000,000
5,079,000,000
-202,000,000
206,000,000
1,191,000,000
-1,622,000,000
-2,419,000,000
-2,030,000,000
-4,864,000,000
16,000,000
-759,000,000
-346,000,000
-532,000,000
-717,000,000
-631,000,000
-1,424,000,000
-597,000,000
430,000,000
571,000,000
-164,000,000
-1,630,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.